Results 11 to 20 of about 53,742 (236)
Pharmacogenomics Instruction Depth, Extent, and Perception in US Medical Curricula
Journal of Medical Education and Curricular Development, 2020 Introduction: This descriptive study aimed to evaluate the depth, extent, and perception of pharmacogenomics instruction in schools and colleges of medicine in the United States.
Dara Basyouni, Aymen Shatnawi
doaj +1 more source
Clinical Application and Educational Training for Pharmacogenomics
Pharmacy, 2020 Pharmacogenomics—defined as the study of how genes affect a person’s response to drugs—is growing in importance for clinical care. Many medications have evidence and drug labeling related to pharmacogenomics and patient care.
Jason W. Guy +2 more
doaj +1 more source
Deciphering next-generation pharmacogenomics: an information technology perspective [PDF]
Open Biology, 2014 In the post-genomic era, the rapid evolution of high-throughput genotyping technologies and the increased pace of production of genetic research data are continually prompting the development of appropriate informatics tools, systems and databases as we ...
George Potamias +6 more
doaj +1 more source
Conference scene : Golden Helix Pharmacogenomics Days : educational activities on pharmacogenomics and personalized medicine [PDF]
, 2012 The Golden Helix Pharmacogenomics Days are high-profile international educational scientific meetings discussing pharmacogenomics and personalized medicine.
Borg, Joseph J. +5 more
core +2 more sources
Computational and Structural Biotechnology Journal, 2022 Background: Pharmacogenomics is crucial for individualized drug therapy and plays an increasingly vital role in precision medicine decision-making.
Xiaoyong Ge +10 more
doaj +1 more source
Neuroscience Letters, 2018 There is high variability in the response to antiepileptic treatment across people with epilepsy. Genetic factors significantly contribute to such variability. Recent advances in the genetics and neurobiology of the epilepsies are establishing the basis for a new era in the treatment of epilepsy, focused on each individual and their specific epilepsy ...
Balestrini S, Sisodiya SM
openaire +4 more sources
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals [PDF]
, 2017 In recent years, great progress has been made in the field of new therapeutic options for hepatitis C virus (HCV) infection. The new direct-acting antiviral agents (DAAs) represent a great hope for millions of chronically infected individuals because ...
Caputo, Mariela +4 more
core +1 more source
Platelet pharmacogenomics [PDF]
Journal of Thrombosis and Haemostasis, 2010 Platelet responsiveness to conventional antiplatelet therapy underlies a high interindividual variability influenced by various factors. For instance, antiplatelet therapy does not curtail the expected effects in a relevant number of patients as demonstrated by the occurrence of repeated cardiovascular events including stent thrombosis and/or by ...
Tobias Geisler +3 more
openaire +3 more sources
The Lancet, 2019 Genomic medicine, which uses DNA variation to individualise and improve human health, is the subject of this Series of papers. The idea that genetic variation can be used to individualise drug therapy-the topic addressed here-is often viewed as within reach for genomic medicine. We have reviewed general mechanisms underlying variability in drug action,
Dan M, Roden +6 more
openaire +3 more sources